L'Oreal S.A. header image

L'Oreal S.A.

OR

Equity

ISIN FR0000120321 / Valor 502805

Euronext - Euronext Paris (2024-09-18)
EUR 365.80-0.69%

L'Oreal S.A.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

L'Oreal S.A. is a global cosmetics company with a unique organizational structure that combines strategic concentration with operational decentralization. The company empowers local teams to ensure that they are close and relevant to consumers in every country, creating and producing cosmetics at a local level to meet the specific needs of each market. L'Oreal has a worldwide network of Research & Innovation and marketing hubs in key strategic markets, supported by a global industrial presence to bring innovations to market efficiently. The company's success is driven by its global R&I, diverse portfolio of brands, and integrated industrial production, along with corporate functions such as Administration & Finance, Digital, HR, Communications, and Corporate Responsibility.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (20.08.2024):

Record Sales Growth

L'Oreal S.A. reported record sales of 41.18 billion euros for the year ending December 31, 2023. This represents a +7.6% increase on a reported basis and an impressive +11.0% growth like-for-like. The company achieved this growth despite challenging market conditions, including geopolitical tensions and a stagnating beauty market in China.

Operating Margin Improvement

L'Oreal S.A. continued to improve its operating margin, reaching 19.8% in 2023, an increase of 30 basis points from the previous year. The operating profit for the year was 8,143.3 million euros, showcasing the company's ability to manage costs effectively while driving revenue growth.

Earnings Per Share and Dividend

The earnings per share (EPS) for L'Oreal S.A. in 2023 were 12.08 euros, marking a +7.3% increase from the previous year. The company also announced a dividend of 6.60 euros per share, which is a +10.0% increase, reflecting its strong financial performance and commitment to returning value to shareholders.

Net Cash Flow

L'Oreal S.A. reported a net cash flow of 6.1 billion euros for 2023, up by +23.9% compared to the previous year. This significant increase in cash flow underscores the company's robust financial health and its ability to generate substantial cash from its operations.

Outlook for 2024

Looking ahead to 2024, L'Oreal S.A. remains optimistic about the beauty market's prospects and confident in its ability to continue outperforming the market. The company aims to achieve another year of growth in sales and profits, driven by its focus on Beauty Tech and its multi-polar model, which has proven effective in navigating diverse market conditions.

Summarized from source with an LLMView Source

Key figures

-9.55%1Y
-4.39%3Y
48.1%5Y

Performance

19.7%1Y
24.1%3Y
24.4%5Y

Volatility

Market cap

229682 M

Market cap (USD)

Daily traded volume (Shares)

366,538

Daily traded volume (Shares)

1 day high/low

368.95 / 364.65

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.06%USD 253.01
Hologic Inc
Hologic Inc Hologic Inc Valor: 939263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.34%USD 81.72
Bruker Corp
Bruker Corp Bruker Corp Valor: 1635622
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.72%USD 66.80
Masimo Corp
Masimo Corp Masimo Corp Valor: 493578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.61%USD 114.31
Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.46%USD 49.91
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc DENTSPLY SIRONA Inc Valor: 31773200
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 26.71
Acadia Healthcare Co Inc
Acadia Healthcare Co Inc Acadia Healthcare Co Inc Valor: 14151414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.22%USD 77.94
Roivant Sciences Limited
Roivant Sciences Limited Roivant Sciences Limited Valor: 113331044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.41%USD 12.00
Apellis Pharmaceuticals Inc
Apellis Pharmaceuticals Inc Apellis Pharmaceuticals Inc Valor: 30132056
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.28%USD 35.63
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%USD 46.23